Cardinal Health (CAH) is scheduled to report Q2 earnings before the market open on Tuesday February 5, with a conference call scheduled for 8:30 am ET. Cardinal Health improves the cost-effectiveness of healthcare. As the business behind healthcare, Cardinal Health helps pharmacies, hospitals and ambulatory care sites focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability... EXPECTATIONS: Analysts are looking for EPS of 86c on revenue of $24.61B, according to First Call. The consensus range for EPS is 84c-88c on revenue of $24.22B-$25.04B... LAST QUARTER: Cardinal Health reported Q1 EPS of 81c against estimates of 79c on revenue of revenue $25.89B, against estimates of $26.35B. At the time of its Q1 results, Cardinal Health gave FY13 EPS guidance of $3.35-$3.50 on analysts consensus estimates of $3.45. The company backed that EPS view at the for J.P. Morgan Healthcare Conference on January 8... STREET RESEARCH: On January 23, RW Baird raised its price target on Cardinal Health shares to $52 from $50, citing earnings leverage, continued generics contributions, growth in platforms outside of drug distribution, and share repurchases. The firm has an Outperform rating on shares of the company... PRICE ACTION: Shares of Cardinal Health have traded lower, after announcing on January 30 that it expects to incur a $79M restructuring charge from a medical segment reorganization. In late afternoon trading, shares of Cardinal Health are trading down less than a percentage point at $43.66.
- Investment & Company Information
- Cardinal Health